Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.

The European respiratory journal - 1 Aug 2016

Pascoe Steven J, Lipson David A, Locantore Nicholas, Barnacle Helen, Brealey Noushin, Mohindra Rajat, Dransfield Mark T, Pavord Ian, Barnes Neil

Abstract excerpt

Patients with symptomatic advanced chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations are particularly at risk of poor outcomes and present a significant burden on healthcare systems. The relative merits of treating with different inhaled combination therapies e.g. inhaled corticosteroids (ICS)/long-acting β2-agonist (LABA), LABA/long-acting muscarinic antagonists (LAMA),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Adrenergic beta-2 Receptor Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Androstadienes

Share to Bronchodilator Agents

Share to Double-Blind Method

Share to Muscarinic Antagonists

Share to Practice Guidelines as Topic

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 27418551
DOI: 10.1183/13993003.02165-2015

Genes

IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.PMID 27418551Read ↗

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.Semantic proximity Read ↗

Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.Semantic proximity Read ↗

New and existing pharmacotherapeutic options for persistent asthma and COPD.Semantic proximity Read ↗

[Toward personalized and integrated treatment of patients with COPD].Semantic proximity Read ↗

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.Semantic proximity Read ↗

Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and SafetySemantic proximity Read ↗

Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping.Semantic proximity Read ↗

Recommendations for COPD management in Central and Eastern Europe.Semantic proximity Read ↗

The COPD pipeline VII.Semantic proximity Read ↗

[Multidimensional impact of COPD exacerbations].Semantic proximity Read ↗

The path to personalised medicine in COPD.Semantic proximity Read ↗

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.